Mediastinal lymphadenopathy may predict 30-day mortality in patients with COVID-19

PURPOSE: There is scarce data on the impact of the presence of mediastinal lymphadenopathy on the prognosis of coronavirus-disease 2019 (COVID-19). We aimed to investigate whether its presence is associated with increased risk for 30-day mortality in a large group of patients with COVID-19. METHOD:...

Descripción completa

Detalles Bibliográficos
Autores principales: Satici, Celal, Cengel, Ferhat, Gurkan, Okan, Demirkol, Mustafa Asim, Altunok, Elif Sargin, Esatoglu, Sinem Nihal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Cardiothoracic Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064813/
https://www.ncbi.nlm.nih.gov/pubmed/33545439
http://dx.doi.org/10.1016/j.clinimag.2021.01.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064813/
https://www.ncbi.nlm.nih.gov/pubmed/33545439
http://dx.doi.org/10.1016/j.clinimag.2021.01.028

Ejemplares similares